Mark G. Charest
Impact in
- Organic Chemistry top 5%
- Synthetic Organic Chemistry Methods
- Asymmetric Synthesis and Catalysis
- Catalytic C–H Functionalization Methods
- Chemical synthesis and alkaloids
- Synthesis and Catalytic Reactions
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in ⓘ
-
- Synthetic Organic Chemistry Methods 2
- Click Chemistry and Applications 2
- Oxidative Organic Chemistry Reactions 1
- Asymmetric Synthesis and Catalysis 1
-
- Chemical Synthesis and Analysis 3
- Co-authors
- Andrew G. Myers (4 shared papers)Dionicio Siegel (4 shared papers)C. Lerner (2 shared papers)Jason D. Brubaker (2 shared papers)Daniel J. Buzard (1 shared paper)Cuixiang Sun (1 shared paper)Peter M. C. Wright (1 shared paper)Yiming Wang (1 shared paper)
- Journals
- Journal of the American Chemical Society (2 papers)Organic Letters (1 paper)Science (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)
- Partner nations
- United States
In The Last Decade
Mark G. Charest
5 papers receiving 487 citations
Peers
Comparison fields: 5 of 53
- Organic Chemistry 342
- Molecular Medicine 56
- Pharmacology 161
- Biotechnology 47
- Toxicology 12
Countries citing papers authored by Mark G. Charest
This map shows the geographic impact of Mark G. Charest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark G. Charest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark G. Charest more than expected).
Fields of papers citing papers by Mark G. Charest
This network shows the impact of papers produced by Mark G. Charest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark G. Charest. The network helps show where Mark G. Charest may publish in the future.
Co-authors
The 23 scholars most cited alongside Mark G. Charest, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 248 | |
| 2 | 2008 | 103 | |
| 3 | 2005 | 98 | |
| 4 | 2001 | 68 | |
| 5 | 2003 | 12 |
About Mark G. Charest
Mark G. Charest is a scholar working on Organic Chemistry, Molecular Biology, Infectious Diseases, Pharmacology and Virology, having authored 5 papers that have together received 529 indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (3 papers), Synthetic Organic Chemistry Methods (2 papers), Click Chemistry and Applications (2 papers), HIV Research and Treatment (1 paper), Oxidative Organic Chemistry Reactions (1 paper), Asymmetric Synthesis and Catalysis (1 paper), HIV/AIDS drug development and treatment (1 paper) and Microbial Natural Products and Biosynthesis (1 paper). The work is most often cited by research in Organic Chemistry (342 citations), Molecular Medicine (56 citations), Pharmacology (161 citations), Biotechnology (47 citations) and Toxicology (12 citations). Mark G. Charest has collaborated with scholars based in United States. Frequent co-authors include Andrew G. Myers, Dionicio Siegel, C. Lerner, Jason D. Brubaker, Daniel J. Buzard, Cuixiang Sun, Peter M. C. Wright, Yiming Wang, Qiu Wang and Kevin Noson. Their work appears in journals such as Journal of the American Chemical Society, Organic Letters, Science and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.